In 1783, a stamp duty was imposed on proprietary or 'quack' medicines. These largely useless but often dangerous remedies were immensely popular. The tax, which lasted until 1941, was imposed to raise revenue. It failed in its incidental regulatory purpose, had a negative effect in that the stamp was perceived as a guarantee of quality, and had a positive effect in encouraging disclosure of the formula. The book explains the considerable impact the tax had on chemists and druggists - how it led to an improvement in professional status, but undermined it by reinforcing their reputations as traders. The legislation imposing the tax was complex, ambiguous and never reformed. The tax authorities had to administer it, and executive practice came to dominate it. A minor, specialised, low-yield tax is shown to be of real significance in the pharmaceutical context, and of exceptional importance as a model revealing the wider impact of tax law and administration.

This book reveals the surprising impact of medicine stamp duty (1783-1941) on pharmaceutical practice and the interface of law and government.

About the Author
Chantal Stebbings is Professor of Law and Legal History at the University of Exeter. In the past she has served as Dean of the Faculty of Law at the University of Exeter, Visiting Professor at the University of Rennes, France and a Fellow of the Institute of Taxation. She has also held a British Academy Research Readership and a Leverhulme Major Research Fellowship. She was generously supported by the Wellcome Trust for this book, which is her fourth monograph for Cambridge University Press. She is the Editor of the Journal of Legal History and the Chair of the Hamlyn Trust.


Book Information
ISBN 9781107025455
Author Chantal Stebbings
Format Hardback
Page Count 256
Imprint Cambridge University Press
Publisher Cambridge University Press
Weight(grams) 480g
Dimensions(mm) 235mm * 158mm * 17mm